Kurt Jaeckle

9PUBLICATIONS
107CO-AUTHORS
Biological adaptationMolecular targetsHaematological tumoursRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Jan 16, 2026
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial.

Priscilla K Brastianos, Katharine Dooley, Susan Geyer

|Sep 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

James J Harding, Do-Youn Oh, Teresa Macarulla Mercade

|Feb 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas.

Mohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson

|Oct 26, 2022
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.

Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner

|Feb 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.

Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer

Pageof 2